Overview

Contraceptives Market is forecasted to value over CAGR of 6.4% from the forecast period 2022-2028.

FutureWise Market Research has illustrated a report that provides an in-depth anatomy of the market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of the market.
The Contraceptives market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Contraceptives market are:   

• The Female Health Company 
• Teva Pharmaceutical Industries Limited
• Allergan plc
• Bayer AG
• Pfizer, Inc.
• Cooper Companies, Inc.
• Ansell LTD.
• Mayer Laboratories
• Merck & Co., Inc.
• Church & Dwight, Co., Inc.

 (Note: The list of the major players will be updated with the latest market scenario and trends)

Contraceptives Market Segmentation:

By Product
• Drugs
  o Oral contraceptive or pills
  o Injectable contraceptives
  o Topical contraceptives
• Contraceptive devices
  o Condoms
    • Female condoms
    • Male condoms
  o Intrauterine devices (IUDs)
    • Hormonal IUDs
    • Copper IUDs
  o Contraceptive diaphragms
  o Contraceptive sponges
  o Contraceptive patches
  o Subdermal contraceptive implants
  o Contraceptive vaginal rings
  o Others

By Age Group
• 15–24 years
• 25–34 years
• 35–44 years
• Above 44 years

By Education
• Less than high school
• High school graduate
• College graduate
• Other college degrees

By End User
• Hospitals      
• Household
• Clinics

By Region
• North America
• Europe
• Asia Pacific 
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players 
• Emerging players which are growing rapidly 
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Contraceptives market by product, by age group, by education, by end user and by region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global Contraceptives Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Contraceptives Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Contraceptives Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Contraceptives Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies

7. Global Contraceptives Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Drugs
        7.1.1. Oral contraceptive or pills
        7.1.2. Injectable contraceptives
        7.1.3. Topical contraceptives
   7.2. Contraceptive devices
        7.2.1. Condoms
               7.2.1.1. Female condoms
               7.2.1.2. Male condoms
        7.2.2. Intrauterine devices (IUDs)
               7.2.2.1. Hormonal IUDs
               7.2.2.2. Copper IUDs
        7.2.3. Contraceptive diaphragms
        7.2.4. Contraceptive sponges
        7.2.5. Contraceptive patches
        7.2.6. Subdermal contraceptive implants
        7.2.7. Contraceptive vaginal rings
        7.2.8. Others
8. Global Contraceptives Market, By Age Group Historical Analysis and Forecast 2022-2028 (USD Million)
         8.1. 15–24 years
         8.2. 25–34 years
         8.3. 35–44 years
         8.4. Above 44 years
9. Global Contraceptives Market, By Education Historical Analysis and Forecast 2022-2028 (USD Million)
        9.1. Less than high school
        9.2. High school graduate
        9.3. College graduate
        9.4. Other college degrees
10. Global Contraceptives Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
        10.1. Hospitals        
        10.2. Household
        10.3. Clinics
11. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2022-2028 
12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2022-2028  
13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  15.2.1. GCC
                  15.2.2. Israel
                  15.2.3. South Africa
                  15.2.4. Rest of MEA
        15.3. Market Size (USD Million) Forecast for MEA 2022-2028           
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
        16.1 The Female Health Company
            16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
        16.2 Teva Pharmaceutical Industries Limited
            16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.2. Product Portfolio
            16.2.3. SWOT Analysis
            16.2.4. Financial Overview
            16.2.5. Strategic Overview
        16.3 Allergan plc
            16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2. Product Portfolio
            16.3.3. SWOT Analysis
            16.3.4. Financial Overview
            16.3.5. Strategic Overview
        16.4 Bayer AG
            16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.4.2. Product Portfolio
            16.4.3. SWOT Analysis
            16.4.4. Financial Overview
            16.4.5. Strategic Overview
        16.5 Pfizer, Inc.
            16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.5.2. Product Portfolio
            16.5.3. SWOT Analysis
            16.5.4. Financial Overview
            16.5.5. Strategic Overview
        16.6 Cooper Companies, Inc.
            16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.6.2. Product Portfolio
            16.6.3. SWOT Analysis
            16.6.4. Financial Overview
            16.6.5. Strategic Overview
        16.7 Ansell LTD.
            16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.7.2. Product Portfolio
            16.7.3. SWOT Analysis
            16.7.4. Financial Overview
            16.7.5. Strategic Overview
        16.8 Mayer Laboratories
            16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.8.2. Product Portfolio
            16.8.3. SWOT Analysis
            16.8.4. Financial Overview
            16.8.5. Strategic Overview
        16.9 Merck & Co., Inc.
            16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.9.2. Product Portfolio
            16.9.3. SWOT Analysis
            16.9.4. Financial Overview
            16.9.5. Strategic Overview
        16.10 Church & Dwight, Co., Inc.
            16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.10.2. Product Portfolio
            16.10.3. SWOT Analysis
            16.10.4. Financial Overview
            16.10.5. Strategic Overview
17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the healthcare regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client

Tables

Figures